ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,665 | +36.0% | 210 | +29.6% | 0.00% | – |
| Q2 2023 | $14,459 | -87.3% | 162 | -84.8% | 0.00% | – |
| Q1 2023 | $113,975 | -22.7% | 1,063 | -12.0% | 0.00% | – |
| Q4 2022 | $147,533 | +13.5% | 1,208 | -3.6% | 0.00% | – |
| Q3 2022 | $130,000 | +44.4% | 1,253 | +29.2% | 0.00% | – |
| Q2 2022 | $90,000 | +25.0% | 970 | +58.2% | 0.00% | – |
| Q1 2022 | $72,000 | -28.7% | 613 | -18.8% | 0.00% | – |
| Q4 2021 | $101,000 | -30.8% | 755 | -17.8% | 0.00% | – |
| Q3 2021 | $146,000 | +47.5% | 919 | +22.0% | 0.00% | – |
| Q2 2021 | $99,000 | -6.6% | 753 | -7.7% | 0.00% | – |
| Q1 2021 | $106,000 | -4.5% | 816 | +23.1% | 0.00% | – |
| Q4 2020 | $111,000 | +9.9% | 663 | +1.7% | 0.00% | – |
| Q3 2020 | $101,000 | -31.8% | 652 | -35.0% | 0.00% | – |
| Q2 2020 | $148,000 | +117.6% | 1,003 | +66.6% | 0.00% | – |
| Q1 2020 | $68,000 | +28.3% | 602 | +56.4% | 0.00% | – |
| Q4 2019 | $53,000 | +231.2% | 385 | +129.2% | 0.00% | – |
| Q3 2019 | $16,000 | -5.9% | 168 | +14.3% | 0.00% | – |
| Q2 2019 | $17,000 | +13.3% | 147 | +12.2% | 0.00% | – |
| Q1 2019 | $15,000 | +200.0% | 131 | +72.4% | 0.00% | – |
| Q4 2018 | $5,000 | 0.0% | 76 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | 0.0% | 76 | 0.0% | 0.00% | – |
| Q2 2018 | $5,000 | 0.0% | 76 | 0.0% | 0.00% | – |
| Q1 2018 | $5,000 | +66.7% | 76 | 0.0% | 0.00% | – |
| Q4 2017 | $3,000 | 0.0% | 76 | 0.0% | 0.00% | – |
| Q3 2017 | $3,000 | +50.0% | 76 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 76 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | 0.0% | 76 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | – | 76 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,909,742 | $911,991,000 | 16.68% |
| Vivo Capital, LLC | 1,797,745 | $277,428,000 | 16.03% |
| Sofinnova Investments, Inc. | 1,109,874 | $171,276,000 | 12.70% |
| Asymmetry Capital Management, L.P. | 81,442 | $12,568,000 | 8.08% |
| Ghost Tree Capital, LLC | 130,000 | $20,062,000 | 5.80% |
| Eversept Partners, LP | 161,004 | $24,846,137 | 5.52% |
| Eventide Asset Management | 1,709,848 | $263,864,000 | 5.16% |
| Avoro Capital Advisors LLC | 1,800,000 | $277,776,000 | 3.95% |
| BERYLSON CAPITAL PARTNERS, LLC | 72,700 | $11,219,000 | 3.93% |
| Spyglass Capital Management LLC | 547,022 | $84,416,000 | 3.90% |